An international team has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells.
A team of researchers have created a method of measuring how circulating tumor cells perform functions that drive cancer, such as producing matrix metalloproteases.
NICE have approved dabrafenib plus trametinib for the adjuvant treatment of resected stage III BRAF V600 mutation-positive melanoma in adults.
In this review article from Future Oncology find out about the PACIFIC trial design as well as the future of immunotherapy combinations and biomarkers beyond PD-L1.
A new study, published in CNS Oncology estimates the survival benefit of adding tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
Immune checkpoint inhibitors revolutionized the treatment of non-small-cell lung cancer, although their costs are a limitation; find out more in this article from Immunotherapy.